Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015.

4th November, 2026 To, The Manager, The Manager, Listing Department, Department of Corporate Services, National Stock Exchange of India Ltd. BSE Limited ‘Exchange Plaza’, Bandra Kurla Complex, P. J. Towers, Dalal Street, Bandra (E), Mumbai – 400 051 Fort, Mumbai – 400 001 NSE Symbol: APLLTD Scrip Code:533573 Dear Sir / Madam, Sub: Updated Contact Details of Key Managerial Personnel pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the captioned matter and as approved by the Board of Directors of the Company at their meeting held today i.e. 4th November, 2026, please find below the updated contact details of persons authorised for the purpose of determining materiality of an event or information and for making disclosures to the Stock Exchange, pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015: Sr. Authorized to Name & Designation Contact Details 1. Mr. Chirayu Amin, 0265 6637000 Determine materiality of an event Executive Chairman or information as well as to make 2. Mr. Pranav Amin, 0265 6637000 disclosures to Stock Exchanges. Managing Director 3. Mr. Shaunak Amin, 0265 6637000 Managing Director 4. Mr. G. Krishnan, 0265 6637000 Chief Financial Officer 5. Mr. Chirag K. Shukla, 0265 6637000 Make Disclosures to Stock Company Secretary Exchanges. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123